9 September 2024
Clifford Chance advises Fresenius on the sale of its Chilean subsidiary Laboratorio Sanderson
Advising firms
Deal team
4 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Javier Amantegui Lead | Clifford Chance | Partner | Not stated | Not stated |
| Beatriz Melo | Clifford Chance | Senior associate | Not stated | Not stated |
| Andreína Velásquez | Clifford Chance | Associate | Not stated | Not stated |
| Sofía Albiñana | Clifford Chance | Associate | Not stated | Not stated |
1 more lawyer on this deal. Register free to see the full deal team, with seniority, practice and office.
REGISTER FREE SIGN INWant co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.
Stated terms
- Stated value
- Not stated
- What the figure measures
- Not stated
- Client
- Fresenius KabiSell-side
- Counterparties
- Medifarma (Buy-side)